Hippocampal iron patterns in aging and mild cognitive impairment
- PMID: 40671787
- PMCID: PMC12263547
- DOI: 10.3389/fnagi.2025.1598859
Hippocampal iron patterns in aging and mild cognitive impairment
Abstract
Introduction: The entorhinal cortex (EC)-hippocampus system is critical for memory and affected early in Alzheimer's disease (AD). Cognitive dysfunction in AD is linked to neuropathological changes, including non-heme iron accumulation in vulnerable brain regions. This study characterized iron distribution in the EC-hippocampus system using ultra-high field (UHF) magnetic resonance imaging (MRI) at 7 Tesla (T) in aging and mild cognitive impairment (MCI), an AD at-risk state.
Methods: 40 participants (mean age [SD] 69.2 [7.42] years; 12 mild cognitive impairment (MCI), 28 cognitively healthy controls (HC)) underwent UHF MRI at 7 T with turbo spin echo and quantitative susceptibility mapping (QSM). Gray matter segmentation was performed using FreeSurfer software. Intraclass correlation coefficients (ICCs) were calculated for hippocampal and EC measures.
Results: ICCs for mean susceptibilities were 0.61 overall, 0.58 for HC, and 0.69 for MCI, with significant group differences between HC and MCI (Kolmogorov-Smirnov test, k = 0.625, p ≤ 0.05).
Discussion: Our findings suggest a higher coherence of non-heme iron distribution in MCI. An increasingly uniform distribution of iron in MCI could reflect a clinical continuum ranging from healthy aging to pathologic brain change and cognitive disorder. This highlights the potential of non-heme iron as a biomarker for early AD co-pathology.
Keywords: 7 tesla; QSM; entorhinal cortex; hippocampus subfields; iron; mild cognitive impairment; real-time field control; ultra-high field MRI.
Copyright © 2025 Kagerer, Vionnet, van Bergen, Meyer, Gietl, Pruessmann, Hock and Unschuld.
Conflict of interest statement
PU serves as a consultant for Eli Lilly and company, which is in accordance with HUG rules of compliance. Within the past five years AG received honoraria as speaker or advisor from Eli Lilly, Biogen AG and OM Pharma. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
References
-
- Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. doi: 10.1016/j.jalz.2011.03.008, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
